Bernard Bénichou

Summary

Affiliation: Genzyme Corporation
Country: USA

Publications

  1. ncbi A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease
    Bernard Bénichou
    Genzyme Europe, 33 35 Bd de la Paix, Parc d activités du Bel Air, 78105 Saint Germain en Laye Cedex, France
    Mol Genet Metab 96:4-12. 2009

Detail Information

Publications1

  1. ncbi A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease
    Bernard Bénichou
    Genzyme Europe, 33 35 Bd de la Paix, Parc d activités du Bel Air, 78105 Saint Germain en Laye Cedex, France
    Mol Genet Metab 96:4-12. 2009
    ....